NASDAQ:ALLO | EBITDA Margin | Allogene Therapeutics, Inc.

Complete source-backed ebitda margin history.

Available history
2021-12-31 to 2024-12-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2024-03-31-299768.18%
2023-12-31-388723.81%

Annual EBITDA Margin

DateEBITDA Margin
2024-12-31-1179818.18%
2023-12-31-330040.00%
2022-12-31-205920.51%
2021-12-31-148.74%